Finzati - Logo
QIPT logo

Quipt Home Medical Corp.

QIPTMedical - Devices
$3.65
0.00 (0.00%)
Current price
EarningsLatest report: Dec 31, 2025
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$159.17M
Growth
Cash Flow
5/5
Trend
Stable
Evidence
Positive revenue growth · 13.9%Positive free cash flow · 0.59Consistent free cash flow · 5/5Manageable debt level · 0.85Healthy liquidity · 1.46
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Feb 10, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$3.65
Change0.00%
Shares Out43.61M
Market Cap$159.17M
Enterprise Value$280.58M
52W Range1.35 - 3.65
Beta0.50
P/E-14.92
P/S0.60
P/B1.15
P/FCF5.96
EV/Sales1.06

Investment DNA

How strong this company looks for long-term investors

63
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
61/100
Growth Potential
Revenue and expansion
86/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score
Positive revenue growth · 13.9%Positive free cash flow · 0.59Consistent free cash flow · 5/5Manageable debt level · 0.85Healthy liquidity · 1.46Weak profitability

Analyst view

Analyst sentiment and price target

QIPT
Analyst sentiment
Based on 2 analyst votes · 2026-09-05
75/100
Bullish
Bullish
1
Hold
1
Bearish
0
Price Target
2026-06-06
Low
$3.65
Mean
$3.65
Median
$3.65
High
$3.65

Company Overview

IPO: 8/10/2010
Industry: Medical - Devices
P/B i: 1.15
Debt / Equity i: 0.85
Operating Margin: -0.80%
Net Margin: -4.36%
ROE i: -
ROIC: -

Financial Health

Score12 / 20
Debt / Equity: 0.85
Current Ratio: 1.46
Quick Ratio: 1.12
Status: Good

Insider Transactions

Recent executive and insider activity

6 high-volume insider sells detected
Mehta Hardik
Transaction: 03/16/2026
SELL
Change
-60,000
Price
$6.27
Filing
03/16/2026
Type
SELL
Mehta Hardik
Transaction: 03/16/2026
SELL
Change
-884,199
Price
$3.65
Filing
03/16/2026
Type
SELL
Bachelder David
Transaction: 03/16/2026
SELL
Change
-30,000
Price
$6.14
Filing
03/16/2026
Type
SELL